 | • レポートコード：QYR2104Z0526 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、自家幹細胞ベース治療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞）、用途別市場規模（神経変性疾患、自己免疫疾患、心血管疾患）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・自家幹細胞ベース治療法の市場動向 ・企業の競争状況、市場シェア ・自家幹細胞ベース治療法の種類別市場規模（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞） ・自家幹細胞ベース治療法の用途別市場規模（神経変性疾患、自己免疫疾患、心血管疾患） ・自家幹細胞ベース治療法の北米市場規模2016-2027（アメリカ、カナダ） ・自家幹細胞ベース治療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・自家幹細胞ベース治療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・自家幹細胞ベース治療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・自家幹細胞ベース治療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Regeneus、Mesoblast、Pluristem Therapeutics Inc、US STEM CELL, INC.、Brainstorm Cell Therapeutics、Tigenix、Med cell Europe） ・結論 |
Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market
The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autologous Stem Cell Based Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autologous Stem Cell Based Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autologous Stem Cell Based Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autologous Stem Cell Based Therapies market.
Global Autologous Stem Cell Based Therapies Scope and Market Size
Autologous Stem Cell Based Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autologous Stem Cell Based Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Embryonic Stem Cell
Resident Cardiac Stem Cells
Umbilical Cord Blood Stem Cells
Segment by Application
Neurodegenerative Disorders
Autoimmune Diseases
Cardiovascular Diseases
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Regeneus
Mesoblast
Pluristem Therapeutics Inc
US STEM CELL, INC.
Brainstorm Cell Therapeutics
Tigenix
Med cell Europe
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Stem Cell Based Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Embryonic Stem Cell
1.2.3 Resident Cardiac Stem Cells
1.2.4 Umbilical Cord Blood Stem Cells
1.3 Market by Application
1.3.1 Global Autologous Stem Cell Based Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Neurodegenerative Disorders
1.3.3 Autoimmune Diseases
1.3.4 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autologous Stem Cell Based Therapies Market Perspective (2016-2027)
2.2 Autologous Stem Cell Based Therapies Growth Trends by Regions
2.2.1 Autologous Stem Cell Based Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autologous Stem Cell Based Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Autologous Stem Cell Based Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Autologous Stem Cell Based Therapies Industry Dynamic
2.3.1 Autologous Stem Cell Based Therapies Market Trends
2.3.2 Autologous Stem Cell Based Therapies Market Drivers
2.3.3 Autologous Stem Cell Based Therapies Market Challenges
2.3.4 Autologous Stem Cell Based Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous Stem Cell Based Therapies Players by Revenue
3.1.1 Global Top Autologous Stem Cell Based Therapies Players by Revenue (2016-2021)
3.1.2 Global Autologous Stem Cell Based Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Autologous Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autologous Stem Cell Based Therapies Revenue
3.4 Global Autologous Stem Cell Based Therapies Market Concentration Ratio
3.4.1 Global Autologous Stem Cell Based Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Stem Cell Based Therapies Revenue in 2020
3.5 Autologous Stem Cell Based Therapies Key Players Head office and Area Served
3.6 Key Players Autologous Stem Cell Based Therapies Product Solution and Service
3.7 Date of Enter into Autologous Stem Cell Based Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Stem Cell Based Therapies Breakdown Data by Type
4.1 Global Autologous Stem Cell Based Therapies Historic Market Size by Type (2016-2021)
4.2 Global Autologous Stem Cell Based Therapies Forecasted Market Size by Type (2022-2027)
5 Autologous Stem Cell Based Therapies Breakdown Data by Application
5.1 Global Autologous Stem Cell Based Therapies Historic Market Size by Application (2016-2021)
5.2 Global Autologous Stem Cell Based Therapies Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Autologous Stem Cell Based Therapies Market Size (2016-2027)
6.2 North America Autologous Stem Cell Based Therapies Market Size by Type
6.2.1 North America Autologous Stem Cell Based Therapies Market Size by Type (2016-2021)
6.2.2 North America Autologous Stem Cell Based Therapies Market Size by Type (2022-2027)
6.2.3 North America Autologous Stem Cell Based Therapies Market Size by Type (2016-2027)
6.3 North America Autologous Stem Cell Based Therapies Market Size by Application
6.3.1 North America Autologous Stem Cell Based Therapies Market Size by Application (2016-2021)
6.3.2 North America Autologous Stem Cell Based Therapies Market Size by Application (2022-2027)
6.3.3 North America Autologous Stem Cell Based Therapies Market Size by Application (2016-2027)
6.4 North America Autologous Stem Cell Based Therapies Market Size by Country
6.4.1 North America Autologous Stem Cell Based Therapies Market Size by Country (2016-2021)
6.4.2 North America Autologous Stem Cell Based Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Autologous Stem Cell Based Therapies Market Size (2016-2027)
7.2 Europe Autologous Stem Cell Based Therapies Market Size by Type
7.2.1 Europe Autologous Stem Cell Based Therapies Market Size by Type (2016-2021)
7.2.2 Europe Autologous Stem Cell Based Therapies Market Size by Type (2022-2027)
7.2.3 Europe Autologous Stem Cell Based Therapies Market Size by Type (2016-2027)
7.3 Europe Autologous Stem Cell Based Therapies Market Size by Application
7.3.1 Europe Autologous Stem Cell Based Therapies Market Size by Application (2016-2021)
7.3.2 Europe Autologous Stem Cell Based Therapies Market Size by Application (2022-2027)
7.3.3 Europe Autologous Stem Cell Based Therapies Market Size by Application (2016-2027)
7.4 Europe Autologous Stem Cell Based Therapies Market Size by Country
7.4.1 Europe Autologous Stem Cell Based Therapies Market Size by Country (2016-2021)
7.4.2 Europe Autologous Stem Cell Based Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Autologous Stem Cell Based Therapies Market Size (2016-2027)
8.2 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Type
8.2.1 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Application
8.3.1 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Region
8.4.1 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Autologous Stem Cell Based Therapies Market Size (2016-2027)
9.2 Latin America Autologous Stem Cell Based Therapies Market Size by Type
9.2.1 Latin America Autologous Stem Cell Based Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Autologous Stem Cell Based Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Autologous Stem Cell Based Therapies Market Size by Type (2016-2027)
9.3 Latin America Autologous Stem Cell Based Therapies Market Size by Application
9.3.1 Latin America Autologous Stem Cell Based Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Autologous Stem Cell Based Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Autologous Stem Cell Based Therapies Market Size by Application (2016-2027)
9.4 Latin America Autologous Stem Cell Based Therapies Market Size by Country
9.4.1 Latin America Autologous Stem Cell Based Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Autologous Stem Cell Based Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous Stem Cell Based Therapies Market Size (2016-2027)
10.2 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Type
10.2.1 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Application
10.3.1 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Country
10.4.1 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Regeneus
11.1.1 Regeneus Company Details
11.1.2 Regeneus Business Overview
11.1.3 Regeneus Autologous Stem Cell Based Therapies Introduction
11.1.4 Regeneus Revenue in Autologous Stem Cell Based Therapies Business (2016-2021)
11.1.5 Regeneus Recent Development
11.2 Mesoblast
11.2.1 Mesoblast Company Details
11.2.2 Mesoblast Business Overview
11.2.3 Mesoblast Autologous Stem Cell Based Therapies Introduction
11.2.4 Mesoblast Revenue in Autologous Stem Cell Based Therapies Business (2016-2021)
11.2.5 Mesoblast Recent Development
11.3 Pluristem Therapeutics Inc
11.3.1 Pluristem Therapeutics Inc Company Details
11.3.2 Pluristem Therapeutics Inc Business Overview
11.3.3 Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Introduction
11.3.4 Pluristem Therapeutics Inc Revenue in Autologous Stem Cell Based Therapies Business (2016-2021)
11.3.5 Pluristem Therapeutics Inc Recent Development
11.4 US STEM CELL, INC.
11.4.1 US STEM CELL, INC. Company Details
11.4.2 US STEM CELL, INC. Business Overview
11.4.3 US STEM CELL, INC. Autologous Stem Cell Based Therapies Introduction
11.4.4 US STEM CELL, INC. Revenue in Autologous Stem Cell Based Therapies Business (2016-2021)
11.4.5 US STEM CELL, INC. Recent Development
11.5 Brainstorm Cell Therapeutics
11.5.1 Brainstorm Cell Therapeutics Company Details
11.5.2 Brainstorm Cell Therapeutics Business Overview
11.5.3 Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Introduction
11.5.4 Brainstorm Cell Therapeutics Revenue in Autologous Stem Cell Based Therapies Business (2016-2021)
11.5.5 Brainstorm Cell Therapeutics Recent Development
11.6 Tigenix
11.6.1 Tigenix Company Details
11.6.2 Tigenix Business Overview
11.6.3 Tigenix Autologous Stem Cell Based Therapies Introduction
11.6.4 Tigenix Revenue in Autologous Stem Cell Based Therapies Business (2016-2021)
11.6.5 Tigenix Recent Development
11.7 Med cell Europe
11.7.1 Med cell Europe Company Details
11.7.2 Med cell Europe Business Overview
11.7.3 Med cell Europe Autologous Stem Cell Based Therapies Introduction
11.7.4 Med cell Europe Revenue in Autologous Stem Cell Based Therapies Business (2016-2021)
11.7.5 Med cell Europe Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Autologous Stem Cell Based Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Embryonic Stem Cell
Table 3. Key Players of Resident Cardiac Stem Cells
Table 4. Key Players of Umbilical Cord Blood Stem Cells
Table 5. Global Autologous Stem Cell Based Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Autologous Stem Cell Based Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Autologous Stem Cell Based Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Autologous Stem Cell Based Therapies Market Share by Regions (2016-2021)
Table 9. Global Autologous Stem Cell Based Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Autologous Stem Cell Based Therapies Market Share by Regions (2022-2027)
Table 11. Autologous Stem Cell Based Therapies Market Trends
Table 12. Autologous Stem Cell Based Therapies Market Drivers
Table 13. Autologous Stem Cell Based Therapies Market Challenges
Table 14. Autologous Stem Cell Based Therapies Market Restraints
Table 15. Global Autologous Stem Cell Based Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Autologous Stem Cell Based Therapies Market Share by Players (2016-2021)
Table 17. Global Top Autologous Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell Based Therapies as of 2020)
Table 18. Ranking of Global Top Autologous Stem Cell Based Therapies Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Autologous Stem Cell Based Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Autologous Stem Cell Based Therapies Product Solution and Service
Table 22. Date of Enter into Autologous Stem Cell Based Therapies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Autologous Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Autologous Stem Cell Based Therapies Revenue Market Share by Type (2016-2021)
Table 26. Global Autologous Stem Cell Based Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Autologous Stem Cell Based Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Autologous Stem Cell Based Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Autologous Stem Cell Based Therapies Revenue Market Share by Application (2016-2021)
Table 30. Global Autologous Stem Cell Based Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Autologous Stem Cell Based Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Autologous Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Autologous Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Autologous Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Autologous Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Autologous Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Autologous Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Autologous Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Autologous Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Autologous Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Autologous Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Autologous Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Autologous Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Autologous Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Autologous Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Autologous Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Autologous Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Autologous Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Autologous Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 62. Regeneus Company Details
Table 63. Regeneus Business Overview
Table 64. Regeneus Autologous Stem Cell Based Therapies Product
Table 65. Regeneus Revenue in Autologous Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 66. Regeneus Recent Development
Table 67. Mesoblast Company Details
Table 68. Mesoblast Business Overview
Table 69. Mesoblast Autologous Stem Cell Based Therapies Product
Table 70. Mesoblast Revenue in Autologous Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 71. Mesoblast Recent Development
Table 72. Pluristem Therapeutics Inc Company Details
Table 73. Pluristem Therapeutics Inc Business Overview
Table 74. Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Product
Table 75. Pluristem Therapeutics Inc Revenue in Autologous Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 76. Pluristem Therapeutics Inc Recent Development
Table 77. US STEM CELL, INC. Company Details
Table 78. US STEM CELL, INC. Business Overview
Table 79. US STEM CELL, INC. Autologous Stem Cell Based Therapies Product
Table 80. US STEM CELL, INC. Revenue in Autologous Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 81. US STEM CELL, INC. Recent Development
Table 82. Brainstorm Cell Therapeutics Company Details
Table 83. Brainstorm Cell Therapeutics Business Overview
Table 84. Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Product
Table 85. Brainstorm Cell Therapeutics Revenue in Autologous Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 86. Brainstorm Cell Therapeutics Recent Development
Table 87. Tigenix Company Details
Table 88. Tigenix Business Overview
Table 89. Tigenix Autologous Stem Cell Based Therapies Product
Table 90. Tigenix Revenue in Autologous Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 91. Tigenix Recent Development
Table 92. Med cell Europe Company Details
Table 93. Med cell Europe Business Overview
Table 94. Med cell Europe Autologous Stem Cell Based Therapies Product
Table 95. Med cell Europe Revenue in Autologous Stem Cell Based Therapies Business (2016-2021) & (US$ Million)
Table 96. Med cell Europe Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Stem Cell Based Therapies Market Share by Type: 2020 VS 2027
Figure 2. Embryonic Stem Cell Features
Figure 3. Resident Cardiac Stem Cells Features
Figure 4. Umbilical Cord Blood Stem Cells Features
Figure 5. Global Autologous Stem Cell Based Therapies Market Share by Application: 2020 VS 2027
Figure 6. Neurodegenerative Disorders Case Studies
Figure 7. Autoimmune Diseases Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Autologous Stem Cell Based Therapies Report Years Considered
Figure 10. Global Autologous Stem Cell Based Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Autologous Stem Cell Based Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Autologous Stem Cell Based Therapies Market Share by Regions: 2020 VS 2027
Figure 13. Global Autologous Stem Cell Based Therapies Market Share by Regions (2022-2027)
Figure 14. Global Autologous Stem Cell Based Therapies Market Share by Players in 2020
Figure 15. Global Top Autologous Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell Based Therapies as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Autologous Stem Cell Based Therapies Revenue in 2020
Figure 17. Global Autologous Stem Cell Based Therapies Revenue Market Share by Type (2016-2021)
Figure 18. Global Autologous Stem Cell Based Therapies Revenue Market Share by Type (2022-2027)
Figure 19. North America Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Autologous Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 21. North America Autologous Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 22. North America Autologous Stem Cell Based Therapies Market Share by Country (2016-2027)
Figure 23. United States Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Autologous Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 27. Europe Autologous Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 28. Europe Autologous Stem Cell Based Therapies Market Share by Country (2016-2027)
Figure 29. Germany Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Autologous Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Autologous Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Autologous Stem Cell Based Therapies Market Share by Region (2016-2027)
Figure 39. China Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Autologous Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 47. Latin America Autologous Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 48. Latin America Autologous Stem Cell Based Therapies Market Share by Country (2016-2027)
Figure 49. Mexico Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Autologous Stem Cell Based Therapies Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Autologous Stem Cell Based Therapies Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Autologous Stem Cell Based Therapies Market Share by Country (2016-2027)
Figure 55. Turkey Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Autologous Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Regeneus Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2016-2021)
Figure 59. Mesoblast Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2016-2021)
Figure 60. Pluristem Therapeutics Inc Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2016-2021)
Figure 61. US STEM CELL, INC. Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2016-2021)
Figure 62. Brainstorm Cell Therapeutics Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2016-2021)
Figure 63. Tigenix Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2016-2021)
Figure 64. Med cell Europe Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の幹細胞臍帯血市場規模・現状・予測（2021年-2027年） Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered uniq…- 世界の犬幹細胞療法市場規模・現状・予測（2021年-2027年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 世界の臍帯血幹細胞市場 2021：企業別、地域別、種類・用途別 The Cord Blood Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の動物用幹細胞治療市場規模・現状・予測（2021年-2027年） Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three …
- 世界の幹細胞治療市場規模・現状・予測（2021年-2027年） Stem Cell Treatment is a method of transplanting healthy stem cells into a patient to repair or replace damaged cells or tissues, thereby achieving the goal of healing. Stem cell transplantation has a wide range of treatments, and can generally treat neurological diseases, immune system diseases, an…